T-cell-specific loss of the PI-3-kinase p110α catalytic subunit results in enhanced cytokine production and antitumor response

13Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Class IA phosphatidylinositol 3-kinase (PI3K) catalytic subunits p110α and p110d are targets in cancer therapy expressed at high levels in T lymphocytes. The role of p110d PI3K in normal or pathological immune responses is well established, yet the importance of p110α subunits in T cell-dependent immune responses is not clear. To address this problem, mice with p110α conditionally deleted in CD4+ and CD8+ T lymphocytes (p110α-/-ΔT) were used. p110α-/-ΔT mice show normal development of T cell subsets, but slightly reduced numbers of CD4+ T cells in the spleen. "In vitro," TCR/CD3 plus CD28 activation of naive CD4+ and CD8+ p110α-/-ΔT T cells showed enhanced effector function, particularly IFN-γ secretion, T-bet induction, and Akt, Erk, or P38 activation. Tfh derived from p110α-/-ΔT cells also have enhanced responses when compared to normal mice, and IL-2 expanded p110α-/-ΔT CD8+ T cells had enhanced levels of LAMP-1 and Granzyme B. By contrast, the expansion of p110α-/-ΔT iTreg cells was diminished. Also, p110α-/-ΔT mice had enhanced anti-keyhole limpet hemocyanin (KLH) IFN-γ, or IL-4 responses and IgG1 and IgG2b anti-KLH antibodies, using CFA or Alum as adjuvant, respectively. When compared to WT mice, p110α-/-ΔT mice inoculated with B16.F10 melanoma showed delayed tumor progression. The percentage of CD8+ T lymphocytes was higher and the percentage of Treg cells lower in the spleen of tumor-bearing p110α-/-ΔT mice. Also, IFN-γ production in tumor antigen-activated spleen cells was enhanced. Thus, PI3K p110α plays a significant role in antigen activation and differentiation of CD4+ and CD8+ T lymphocytes modulating antitumor immunity.

Cite

CITATION STYLE

APA

Aragoneses-Fenoll, L., Ojeda, G., Montes-Casado, M., Acosta-Ampudia, Y., Dianzani, U., Portolés, P., & Rojo, J. M. (2018). T-cell-specific loss of the PI-3-kinase p110α catalytic subunit results in enhanced cytokine production and antitumor response. Frontiers in Immunology, 9(FEB). https://doi.org/10.3389/fimmu.2018.00332

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free